Cargando…
Neurocysticercosis in Latin America: Current epidemiological situation based on official statistics from four countries
BACKGROUND: Neurocysticercosis (NC) is one of the major parasitic diseases affecting the central nervous system and is endemic in much of Asia, sub-Saharan Africa, and Latin America. Its epidemiology is difficult to assess, although official registries are available in Brazil, Colombia, Ecuador, and...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462807/ https://www.ncbi.nlm.nih.gov/pubmed/36037251 http://dx.doi.org/10.1371/journal.pntd.0010652 |
_version_ | 1784787272597504000 |
---|---|
author | Rodríguez-Rivas, Roberto Flisser, Ana Norcia, Luiz Fernando Hamamoto Filho, Pedro Tadao Bonilla-Aldana, D. Katterine Rodriguez-Morales, Alfonso J. Carpio, Arturo Romo, Matthew L. Fleury, Agnès |
author_facet | Rodríguez-Rivas, Roberto Flisser, Ana Norcia, Luiz Fernando Hamamoto Filho, Pedro Tadao Bonilla-Aldana, D. Katterine Rodriguez-Morales, Alfonso J. Carpio, Arturo Romo, Matthew L. Fleury, Agnès |
author_sort | Rodríguez-Rivas, Roberto |
collection | PubMed |
description | BACKGROUND: Neurocysticercosis (NC) is one of the major parasitic diseases affecting the central nervous system and is endemic in much of Asia, sub-Saharan Africa, and Latin America. Its epidemiology is difficult to assess, although official registries are available in Brazil, Colombia, Ecuador, and Mexico. METHODOLOGY/PRINCIPAL FINDINGS: Using official statistics, we assessed trends in NC hospitalization rates during 1998–2019 in Brazil and Ecuador, during 2004–2019 in Mexico, and during 2009–2019 in Colombia. We also assessed the trend in NC mortality in Brazil (1998–2019), the trend in hospitalizations for NC in a Mexican tertiary-level hospital (Instituto Nacional de Neurología y Neurocirugía [INNN]; 1995–2019), and in Mexican primary care ambulatory clinics (1995–2019). Associations between NC hospitalization rates and the human development index (HDI) were also examined. In Brazil, Ecuador, and Mexico, statistically significant decreases in NC hospitalization rates were observed. In Mexico, a significant increase in the age of patients at INNN was observed, suggesting a decreasing incidence of recent infection. Conversely, a significant increase in NC hospitalization rate was observed in Colombia. HDI was not significantly associated with NC hospitalization rates when adjusting for time. CONCLUSIONS: The downward trends in NC cases in Brazil, Ecuador, and Mexico are encouraging, especially in the context of the PAHO/WHO plan of action to eliminate neglected tropical diseases from the region. On the other hand, in Colombia, the increased NC hospitalization rate is concerning and needs further evaluation so that the authorities can take specific measures. These results should encourage health authorities in other endemic countries to establish a system of official registries to identify where the need for a control program is most urgent. However, it is also important to remember that NC persists, although less frequently in some Latin American countries, and efforts to achieve its control must continue. |
format | Online Article Text |
id | pubmed-9462807 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-94628072022-09-10 Neurocysticercosis in Latin America: Current epidemiological situation based on official statistics from four countries Rodríguez-Rivas, Roberto Flisser, Ana Norcia, Luiz Fernando Hamamoto Filho, Pedro Tadao Bonilla-Aldana, D. Katterine Rodriguez-Morales, Alfonso J. Carpio, Arturo Romo, Matthew L. Fleury, Agnès PLoS Negl Trop Dis Research Article BACKGROUND: Neurocysticercosis (NC) is one of the major parasitic diseases affecting the central nervous system and is endemic in much of Asia, sub-Saharan Africa, and Latin America. Its epidemiology is difficult to assess, although official registries are available in Brazil, Colombia, Ecuador, and Mexico. METHODOLOGY/PRINCIPAL FINDINGS: Using official statistics, we assessed trends in NC hospitalization rates during 1998–2019 in Brazil and Ecuador, during 2004–2019 in Mexico, and during 2009–2019 in Colombia. We also assessed the trend in NC mortality in Brazil (1998–2019), the trend in hospitalizations for NC in a Mexican tertiary-level hospital (Instituto Nacional de Neurología y Neurocirugía [INNN]; 1995–2019), and in Mexican primary care ambulatory clinics (1995–2019). Associations between NC hospitalization rates and the human development index (HDI) were also examined. In Brazil, Ecuador, and Mexico, statistically significant decreases in NC hospitalization rates were observed. In Mexico, a significant increase in the age of patients at INNN was observed, suggesting a decreasing incidence of recent infection. Conversely, a significant increase in NC hospitalization rate was observed in Colombia. HDI was not significantly associated with NC hospitalization rates when adjusting for time. CONCLUSIONS: The downward trends in NC cases in Brazil, Ecuador, and Mexico are encouraging, especially in the context of the PAHO/WHO plan of action to eliminate neglected tropical diseases from the region. On the other hand, in Colombia, the increased NC hospitalization rate is concerning and needs further evaluation so that the authorities can take specific measures. These results should encourage health authorities in other endemic countries to establish a system of official registries to identify where the need for a control program is most urgent. However, it is also important to remember that NC persists, although less frequently in some Latin American countries, and efforts to achieve its control must continue. Public Library of Science 2022-08-29 /pmc/articles/PMC9462807/ /pubmed/36037251 http://dx.doi.org/10.1371/journal.pntd.0010652 Text en © 2022 Rodríguez-Rivas et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Rodríguez-Rivas, Roberto Flisser, Ana Norcia, Luiz Fernando Hamamoto Filho, Pedro Tadao Bonilla-Aldana, D. Katterine Rodriguez-Morales, Alfonso J. Carpio, Arturo Romo, Matthew L. Fleury, Agnès Neurocysticercosis in Latin America: Current epidemiological situation based on official statistics from four countries |
title | Neurocysticercosis in Latin America: Current epidemiological situation based on official statistics from four countries |
title_full | Neurocysticercosis in Latin America: Current epidemiological situation based on official statistics from four countries |
title_fullStr | Neurocysticercosis in Latin America: Current epidemiological situation based on official statistics from four countries |
title_full_unstemmed | Neurocysticercosis in Latin America: Current epidemiological situation based on official statistics from four countries |
title_short | Neurocysticercosis in Latin America: Current epidemiological situation based on official statistics from four countries |
title_sort | neurocysticercosis in latin america: current epidemiological situation based on official statistics from four countries |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462807/ https://www.ncbi.nlm.nih.gov/pubmed/36037251 http://dx.doi.org/10.1371/journal.pntd.0010652 |
work_keys_str_mv | AT rodriguezrivasroberto neurocysticercosisinlatinamericacurrentepidemiologicalsituationbasedonofficialstatisticsfromfourcountries AT flisserana neurocysticercosisinlatinamericacurrentepidemiologicalsituationbasedonofficialstatisticsfromfourcountries AT norcialuizfernando neurocysticercosisinlatinamericacurrentepidemiologicalsituationbasedonofficialstatisticsfromfourcountries AT hamamotofilhopedrotadao neurocysticercosisinlatinamericacurrentepidemiologicalsituationbasedonofficialstatisticsfromfourcountries AT bonillaaldanadkatterine neurocysticercosisinlatinamericacurrentepidemiologicalsituationbasedonofficialstatisticsfromfourcountries AT rodriguezmoralesalfonsoj neurocysticercosisinlatinamericacurrentepidemiologicalsituationbasedonofficialstatisticsfromfourcountries AT carpioarturo neurocysticercosisinlatinamericacurrentepidemiologicalsituationbasedonofficialstatisticsfromfourcountries AT romomatthewl neurocysticercosisinlatinamericacurrentepidemiologicalsituationbasedonofficialstatisticsfromfourcountries AT fleuryagnes neurocysticercosisinlatinamericacurrentepidemiologicalsituationbasedonofficialstatisticsfromfourcountries |